Evidence map›Paper›PMID 38376604›Full record

ArticleActa neuropathologica2024

Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas.

Naomi Zakimi, Christina N Mazcko, Christine Toedebusch, Gregory Tawa, Kevin Woolard, Amy K LeBlanc, Peter J Dickinson, David R Raleigh

Open access · hybridAbstract readLetter
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Naomi ZakimiDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Christina N MazckoComparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Christine ToedebuschDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Gregory TawaTherapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Kevin WoolardDepartment of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Amy K LeBlancComparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. amy.leblanc@nih.gov.
Peter J DickinsonDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA. pjdickinson@ucdavis.edu.
David R RaleighDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.ORCID 0000-0001-9299-8864
National Institutes of Health · USUniversity of California, Davis · USUniversity of California, San Francisco · US

Funding

UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development ProgramK12CA138464 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, LARA, PRIMO N. · 2011 to 2025
$11.4M
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomicsZIATR000249 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI TAWA, GREGORY · 2016 to 2025
$5.5M
Genetic Characterization of Canine Brain TumorsZIATR000427 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI TAWA, GREGORY · 2020 to 2025
$3.3M
Understanding druggable drivers of meningioma tumorigenesisR01CA262311 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RALEIGH, DAVID R · 2021 to 2025
$2.7M
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGSZ01BC006161 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Comparative Brain Tumor ConsortiumZIABC011696 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEBLANC, AMY · 2016 to 2025
$859k
Intramural NIH HHS Z01 BC006161Intramural NIH HHS ZIA TR000249NCI NIH HHS K12 CA138464NCI NIH HHS R01 CA262311
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Meningeal NeoplasmsMeningiomaAnimalsDNA MethylationDogsHumans

Identifiers

PMID38376604
PMCPMC10879255
OpenAlexW4391969190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.